On July 13, 2018, the FDA announced a voluntary recall of some valsartan products because of contamination with NDMA, a potentially cancer-causing chemical. Other drugs affected by the valsartan recall include losartan and irbesartan.Why Was Valsartan Recalled? Drug manufacturers issued valsartan ...